Synthesis and luminescence monitoring of iridium(III) complex-functionalized gold nanoparticles and their application for determination of gold(III) ions

A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability

Hepatocellular carcinoma (HCC) is a major contributor to global mortality rates, but current treatment options have limitations. Advanced theranostics are needed to effectively integrate diagnosis and therapeutic of HCC. Glycyrrhetinic acid (GA) has abundant binding sites with glycyrrhetinic acid receptors (GA-Rs) on the surface of HCC cells and has also been reported to possess ligands with mitochondrial-targeting capability but with limited efficacy. Herein, we report a near-infrared (NIR) luminescent theranostic complex 1 through conjugating an iridium(III) complex to GA, which exhibits the desired photophysical properties and promotes mitochondrial-targeting capability. Complex 1 was selectively taken up by HepG2 liver cancer cells and was imaged within mitochondria with NIR emission. Complex 1 targeted mitochondria and opened mitochondrial permeability transition pores (MPTPs), resulting in ROS accumulation, mitochondrial damage, disruption of Bax/Bcl-2 equilibrium, and tumor cell apoptosis, resulting in significantly improved anticancer activity compared to GA. This work offers a methodology for developing multifunctional theranostic probes with amplified specificity and efficacy.

Recent Advances in Organometallic NIR Iridium(III) Complexes for Detection and Therapy

Iridium(III) complexes are emerging as a promising tool in the area of detection and therapy due to their prominent photophysical properties, including higher photostability, tunable phosphorescence emission, long-lasting phosphorescence, and high quantum yields. In recent years, much effort has been devoted to develop novel near-infrared (NIR) iridium(III) complexes to improve signal-to-noise ratio and enhance tissue penetration. In this review, we summarize different classes of organometallic NIR iridium(III) complexes for detection and therapy, including cyclometalated ligand-enabled NIR iridium(III) complexes and NIR-dye-conjugated iridium(III) complexes. Moreover, the prospects and challenges for organometallic NIR iridium(III) complexes for targeted detection and therapy are discussed.

Colorimetric determination and recycling of gold(III) ions using label-free plasmonic H0.3MoO3 nanoparticles

A low-cost and environment-friendly sensor was developed for visual determination of gold ions (Au³⁺) by using label-free hydrogen doped molybdenum oxide (H_0.3MoO₃) nanoparticles as ratio probes. According to the characterization results of transmission electron microscopy, scanning electron microscopy, X-ray powder diffraction, and Fourier transform infrared spectra, Au³⁺ is easily reduced to red Au nanoparticles (AuNPs) by blue H_0.3MoO₃ nanoparticles. The color change of the solution depends on the concentration of Au³⁺, which makes it possible to detect Au³⁺ visually. Under optimal experimental conditions of pH 4.6, H_0.3MoO₃ nanoparticles concentration of 0.075 mg·mL^-1, and reaction time of 7 min, the sensor offers a satisfactory determination range from 0.5 to 70 μM and a good determination limit of 0.45 μM for Au³⁺. The concentration of Au³⁺ as low as 10 μM can be directly distinguished through the naked eye. Additionally, the colorimetric probe has also been proved applicable in environmental water samples. More importantly, the resulting AuNPs have good stability and oxidase-like activity, which may be directly used in sensing, catalysis, energy, and other fields.